Axogen Inc

Research Axogen Inc (AXGN) on Bullrun: market cap USD 2.38B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAXGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 2.38B
• Financial periodFY2025
• RevenueUSD 225.21M
• Revenue growth20.2%
• Net income-USD 15.70M
• Free cash flow-USD 2.93M
• Gross margin74.3%

Valuation Snapshot

latest market cap is USD 2.38B.

About Axogen Inc

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair;

Frequently asked questions

What is Axogen Inc's market cap?

Axogen Inc's market capitalization is USD 2.38B.

What does Axogen Inc do?

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide.